Cargando…
A potential therapeutic peptide-based neutralizer that potently inhibits Shiga toxin 2 in vitro and in vivo
Shiga toxin 2 (Stx2) is a major virulence factor in infections with Stx-producing Escherichia coli (STEC), which can cause serious clinical complications in humans, such as hemolytic uremic syndrome (HUS). Recently, we screened and identified two peptide-based Stx2 neutralizers, TF-1 and WA-8, which...
Autores principales: | Li, Tao, Tu, Wei, Liu, Yuenan, Zhou, Peng, Cai, Kun, Li, Zhan, Liu, Xiong, Ning, Nianzhi, Huang, Jie, Wang, Shenghan, Huang, Jian, Wang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763182/ https://www.ncbi.nlm.nih.gov/pubmed/26903273 http://dx.doi.org/10.1038/srep21837 |
Ejemplares similares
-
Shiga Toxin Therapeutics: Beyond Neutralization
por: Hall, Gregory, et al.
Publicado: (2017) -
A Multi-Specific DARPin Potently Neutralizes Shiga Toxin 2 via Simultaneous Modulation of Both Toxin Subunits
por: Zeng, Yu, et al.
Publicado: (2022) -
Mouse in Vivo Neutralization of Escherichia coli Shiga Toxin 2 with Monoclonal Antibodies
por: Cheng, Luisa W., et al.
Publicado: (2013) -
Identification of a peptide motif that potently inhibits two functionally distinct subunits of Shiga toxin
por: Watanabe-Takahashi, Miho, et al.
Publicado: (2021) -
In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2
por: Jeong, Kwang-il, et al.
Publicado: (2010)